Fund profile by ISIN IE000GTBEXG4
Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Acc
Research Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD Acc by ISIN IE000GTBEXG4: TER 0.20%, domicile Ireland, accumulating, and 1-year price performance -7.1%.
This fund 0.20% · cheapest same-index 0.20% · median 0.30%
9 of 9 ETFs tracking the Russell 2000 publish an ongoing charge. Compare every Russell 2000 ETF by cost.
Exchange listings and tradability
| Ticker | Exchange | Currency | Country | Avg daily turnover | Avg daily shares |
|---|---|---|---|---|---|
| VRSA.SW | SW | USD | Ireland | €37K | 431 |
| V2SA.DE | XETRADefault at German brokers | EUR | Ireland | €28K | 328 |
| VRSA.MI | ETFP | EUR | Ireland | €9K | 107 |
| VRSA.AS | XAMS | EUR | Ireland | — | — |
Avg daily turnover is the 90-day average, converted to euros so venues in different currencies can be compared; avg daily shares is the same window in units. The most traded listing is shown first. This fund trades on a German exchange. As of 2026-10-12.
Largest holdings
The 10 largest holdings make up 3.16% of the fund, which holds 1,950 positions in total. As of 2026-08-31.
| Holding | Symbol | Weight |
|---|---|---|
| JFrog Ltd | FROG | 0.35% |
| Moog Inc | MOG/A | 0.34% |
| UMB Financial Corp | UMBF | 0.34% |
| Glaukos Corp | GKOS | 0.33% |
| Brinker International Inc | EAT | 0.32% |
| BrightSpring Health Services Inc | BTSG | 0.31% |
| Krystal Biotech Inc | KRYS | 0.30% |
| Cytokinetics Inc | CYTK | 0.30% |
| Protagonist Therapeutics Inc | PTGX | 0.29% |
| SM Energy Co | SM | 0.29% |
Performance is the historical price return of the representative listing. Distributions are excluded and past performance is not a forecast.